Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.

Arquivos brasileiros de cardiologia - 1 Jul 2017

Mesquita Evandro Tinoco, Jorge Antonio José Lagoeiro, Souza Celso Vale, Andrade Thais Ribeiro de

Abstract excerpt

Heart failure with preserved ejection fraction (HFpEF) is now an emerging cardiovascular epidemic, being identified as the main phenotype observed in clinical practice. It is more associated with female gender, advanced age and comorbidities such as hypertension, diabetes, obesity and chronic kidney disease. Amyloidosis is a clinical disorder characterized by the deposition of aggregates of insoluble fibrils...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Stroke Volume

Source

Open in PubMed Open full text

Identifiers

PMID: 28678923
DOI: 10.5935/abc.20170079
PMCID: PMC5524478

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.PMID 28678923Read ↗

Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.Semantic proximity Read ↗

Unraveling the Complexity: From Molecular Subtypes to Therapeutic Strategies in Heart Failure with Preserved Ejection Fraction and Atrial FibrillationSemantic proximity Read ↗

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Semantic proximity Read ↗

Amyloid Cardiomyopathy.Semantic proximity Read ↗

Pathophysiology and treatment of cardiac amyloidosis.Semantic proximity Read ↗

Small Hearts, Big Clues: Amyloidosis in WomenSemantic proximity Read ↗

[Hypertrophic cardiomyopathies and ATTR amyloidosis - a current review for clinical practice].Semantic proximity Read ↗

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Semantic proximity Read ↗

[Amyloidosis of the heart].Semantic proximity Read ↗

Amyloid heart disease.Semantic proximity Read ↗

Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.